# Exenatide and Weight Loss for Diabetes Prevention

> **NCT02084654** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 66 (actual)

## Conditions studied

- Pre Diabetes
- Insulin Resistance

## Interventions

- **DRUG:** Exenatide 5 and 10 mcg 2 times a day
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02084654
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2012-10
- **Final completion:** 2013-02
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2016-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084654, "Exenatide and Weight Loss for Diabetes Prevention". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02084654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*